We value your privacy
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
No cookies to display.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
No cookies to display.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
No cookies to display.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
No cookies to display.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
No cookies to display.
Brain-computer interface (BCI) startup founded by Elon Musk In preparation for its first human trial, Neuralink has started hiring employees.
The business intends to test its technique on paralyzed individuals as part of its mission to link human brains to computers.
A BCI will be implanted with the assistance of a robot, enabling users to operate a computer cursor or type with just their thoughts.
However, BCI implants have previously been made by other businesses in people.
After prior attempts to obtain permission, Neuralink finally received US Food and Drug Administration (FDA) approval for its first human clinical trial in May. This was a significant step.
According to Neuralink at the time, the FDA approval constituted “an important first step that will one day allow our technology to help many people.”
According to former and present employees who spoke to the news agency Reuters, the business requested permission to implant its gadgets in 10 persons.
The final number that was chosen is unknown.
64 flexible threads, each no thicker than a human hair, would be surgically implanted on a region of the brain that managed “movement intention” at the beginning of the six-year trial, according to the company.
These enable Neuralink’s experimental N1 implant, which runs on a remotely rechargeable battery, to record and transmit brain impulses to an app that decodes a person’s intended movement.
According to the business, individuals with amyotrophic lateral sclerosis (ALS), a condition in which the nerve cells in the spinal cord and brain deteriorate, or quadriplegia resulting from an injury may be eligible for the experiment.
While Mr. Musk’s involvement helps Neuralink become more well-known, he still has competitors, some of whom have a history going back almost two decades. In 2004, Blackrock Neurotech, a company based in Utah, implanted the first of several BCIs.
A Neuralink co-founder founded Precision Neuroscience with the intention of assisting those who are paralyzed. And it claims that its implant, which resembles a very thin piece of tape and rests on the surface of the brain, may be inserted via a “cranial micro-slit” in a much less complicated manner.
In the meanwhile, existing technology is producing results. Implants were utilized in two different recent US scientific investigations to track brain activity during speech attempts, which might later be decoded to aid with communication.
According to Dr. Adrien Rapeaux, a research associate at Imperial College London’s Neural Interfaces Lab, “Neuralink no doubt has an advantage in terms of implantation” because their surgery was robotically assisted.
However, Dr. Rapeaux, who is also a co-founder of the neural implant start-up Mintneuro, said it was unclear how their approach to translating brain signals into actionable decisions would perform better than, for instance, that employed by Blackrock Neurotech, and whether it is able to remain accurate and reliable over time, “a known issue in the field.”
© 2023 Global Updates